Business
Mesoblast share price crashes 29% lower on FDA doubts – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is crashing lower on Tuesday after doubts were raised ahead of its key FDA meeting…
The Mesoblast limited(ASX: MSB) share price has been the worst performer on the S&P/ASX 200 Index (ASX: XJO) by some distance on Tuesday.
In afternoon trade the biotechnology company’s shares are down 26% to $3.62.
At one stage, the Mesoblast share price was down as much as 29% to $3.46.
Why is the Mesoblast share price crashing lower?
Investors have been hitting the sell button in a panic on Tuesday after the U.S. Food and Drug Administration (FDA) released a briefing document ahead of …
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business24 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News18 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland